Treatment outcome and survival in participants of phase I oncology trials carried out from 2003 to 2006 at Institut Gustave Roussy.

Italiano, A; Massard, C; Bahleda, R; Vataire, A-L; Deutsch, E; Magné, N; Pignon, J-P; Vassal, G; Armand, J-P; Soria, J-C

Italiano, A; Massard, C; Bahleda, R; Vataire, A-L; Deutsch, E; Magné, N; Pignon, J-P; Vassal, G; Armand, J-P; Soria, J-C.

Affiliation

Italiano A; Department of Medicine, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif Cedex, France.

Ann Oncol ; 19(4): 787-92, 2008 Apr.

Article in En | MEDLINE | ID: mdl-18042834

Subject(s)

Antineoplastic Agents/pharmacology; Antineoplastic Agents/therapeutic use; Neoplasms/mortality; Neoplasms/therapy; Adult; Aged; Aged, 80 and over; Antineoplastic Agents/adverse effects; Antineoplastic Agents/pharmacokinetics; Antineoplastic Agents, Hormonal/therapeutic use; Clinical Trials, Phase I as Topic; Disease-Free Survival; Female; France/epidemiology; Humans; Immunotherapy; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Neoplasms/drug therapy; Neoplasms/immunology; Neoplasms/radiotherapy; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Neoplasms / Antineoplastic Agents Type of study: Prognostic_studies / Systematic_reviews Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2008 Type: Article Affiliation country: France

Search on Google

XML

PubMed Links